SCHEMBL19625337

SCHEMBL19625337

CCOc1ccc(-c2csc(C(C)(C)C)n2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.42
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41
TUBB8 Q3ZCM7 2/20 0.41
TUBA3E Q6PEY2 2/20 0.41
TUBA1A Q71U36 2/20 0.41
TUBA1C Q9BQE3 2/20 0.41
TUBB6 Q9BUF5 2/20 0.41
TUBB2B Q9BVA1 2/20 0.41
TUBB1 Q9H4B7 2/20 0.41
CDC25A P30304 1/20 0.41
CDC25B P30305 1/20 0.41
CDC25C P30307 1/20 0.41
DUSP3 P51452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625343 0.90 CDC25A (0.41) CDC25ACDC25BCDC25CDUSP3GRM2
SCHEMBL19627006 0.85 MAPT (0.53) KMT2ACDC25ACDC25BCDC25CDUSP3
SCHEMBL19625311 0.85 MAPT (0.50) KMT2AEIF4EMAPTRAB9AL3MBTL1
SCHEMBL19625435 0.81 CDC25A (0.39) KMT2ACDC25ACDC25BCDC25CDUSP3
SCHEMBL13650700 0.81 CYP1A2 (0.53) KMT2AEIF4EMAPTRAB9AKDM4E
SCHEMBL19625431 0.80 CDC25A (0.42) KMT2ACDC25ACDC25BCDC25CDUSP3
SCHEMBL19625433 0.79 CDC25A (0.39) KMT2ACDC25ACDC25BCDC25CDUSP3
SCHEMBL19625424 0.79 CDC25A (0.57) KMT2ACDC25ACDC25BCDC25CDUSP3
SCHEMBL19625369 0.77 MAPT (0.38) KMT2AMAPTCOMTRAB9AKDM4E
SCHEMBL19625313 0.77 ABL1 (0.55) KMT2AEIF4EMAPTCOMTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 KMT2A 3504/4885TUBB4A 3544/4885TUBB 3560/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 KMT2A 3504/4885TUBB4A 3544/4885TUBB 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.